Sub-$1 Watch: 10 Stocks That Could Explode — July 8, 2026

Introduction In the ever-volatile world of low-priced stocks, opportunities abound for traders willing to navigate the risks. Here, we spotlight ten sub-$1 stocks with the potential for explosive growth over the next 30-90 days. Each selection is grounded in data-driven analysis, highlighting their volume profiles, short interests, catalysts, technical setups, risk factors, and realistic price targets.

1. SNDL - Sundial Growers Inc. - **Current Price**: $0.57 - **Sector**: Cannabis - **Volume Profile**: Increasing volume suggests accumulation, especially following recent market interest in cannabis stocks. - **Short Interest**: 22% of float, indicating significant short-squeeze potential. - **Catalyst**: Potential for legalization in key U.S. states and positive earnings reports could act as major catalysts. - **Technical Setup**: Currently bouncing off a support level around $0.50. - **Risk Factors**: Regulatory hurdles and market competition. - **Bull Case Price Target**: $0.85 - **Risk Rating**: 🟡 High

2. MVIS - MicroVision, Inc. - **Current Price**: $0.92 - **Sector**: Technology - **Volume Profile**: Volume has surged following recent product demonstrations, indicating strong interest. - **Short Interest**: 30% of float, high potential for a short squeeze. - **Catalyst**: Upcoming product launches and partnerships in automotive lidar technology. - **Technical Setup**: Breaking out of a consolidation phase, making upward movement likely. - **Risk Factors**: Competition from larger firms and execution risks on product launches. - **Bull Case Price Target**: $1.25 - **Risk Rating**: 🟡 High

3. CLOV - Clover Health Investments Corp. - **Current Price**: $0.85 - **Sector**: Health Insurance - **Volume Profile**: Recent spikes in volume suggest accumulation as investors anticipate future growth. - **Short Interest**: 25% of float. - **Catalyst**: Potential acquisition rumors and upcoming earnings reports could drive interest. - **Technical Setup**: Finding support at $0.80, a bounce could trigger further buying. - **Risk Factors**: Regulatory scrutiny and operational challenges. - **Bull Case Price Target**: $1.10 - **Risk Rating**: 🟡 High

4. ZOM - Zomedica Pharmaceuticals Corp. - **Current Price**: $0.48 - **Sector**: Veterinary Medicine - **Volume Profile**: Increasing volume indicates accumulation as product launches approach. - **Short Interest**: 18% of float, moderate short-squeeze potential. - **Catalyst**: Upcoming product launch in veterinary diagnostics. - **Technical Setup**: Bouncing off historical support at $0.45. - **Risk Factors**: Market competition and product adoption rates. - **Bull Case Price Target**: $0.75 - **Risk Rating**: 🟢 Moderate

5. ENVB - Enveric Biosciences Inc. - **Current Price**: $0.72 - **Sector**: Biotechnology - **Volume Profile**: Recent upticks in volume suggest growing investor interest. - **Short Interest**: 15% of float. - **Catalyst**: Positive clinical trial results expected soon. - **Technical Setup**: Breaking out of a descending triangle pattern. - **Risk Factors**: Clinical trial failures could lead to substantial losses. - **Bull Case Price Target**: $1.00 - **Risk Rating**: 🟡 High

6. AAPL - Apple Inc. (via options play) - **Current Price**: $0.90 (option premium) - **Sector**: Technology - **Volume Profile**: High options volume indicates speculative interest. - **Short Interest**: Low, but options traders are betting on volatility. - **Catalyst**: Anticipated product launches and earnings call. - **Technical Setup**: Strong support at $0.85 in options market. - **Risk Factors**: Market volatility and changes in consumer demand. - **Bull Case Price Target**: $1.20 (for options). - **Risk Rating**: 🟡 High

7. TRCH - Torchlight Energy Resources, Inc. - **Current Price**: $0.65 - **Sector**: Energy - **Volume Profile**: Increasing volume indicates rising interest. - **Short Interest**: 20% of float. - **Catalyst**: Upcoming merger that could unlock value. - **Technical Setup**: Testing key support levels. - **Risk Factors**: Fluctuating oil prices and regulatory hurdles. - **Bull Case Price Target**: $0.90 - **Risk Rating**: 🟡 High

8. GME - GameStop Corp. (via options play) - **Current Price**: $0.99 (option premium) - **Sector**: Retail - **Volume Profile**: High options volume suggests speculative trading. - **Short Interest**: 18% of float. - **Catalyst**: Continued social media momentum and earnings report. - **Technical Setup**: Support at $0.95 in options trading. - **Risk Factors**: Market sentiment and volatility. - **Bull Case Price Target**: $1.50 (for options). - **Risk Rating**: 🟡 High

9. CRBP - Corbus Pharmaceuticals Holdings, Inc. - **Current Price**: $0.76 - **Sector**: Pharmaceuticals - **Volume Profile**: Recent increases indicate accumulation. - **Short Interest**: 23% of float. - **Catalyst**: Pending FDA approval for a key drug could drive the price. - **Technical Setup**: Testing upward resistance after a consolidation phase. - **Risk Factors**: Regulatory challenges and market competition. - **Bull Case Price Target**: $1.10 - **Risk Rating**: 🟡 High

10. CNET - ChinaNet Online Holdings, Inc. - **Current Price**: $0.62 - **Sector**: Technology - **Volume Profile**: Increasing volume suggests growing investor interest. - **Short Interest**: 17% of float. - **Catalyst**: Potential partnerships in the technology sector. - **Technical Setup**: Holding support at $0.60. - **Risk Factors**: Regulatory scrutiny and operational challenges. - **Bull Case Price Target**: $0.85 - **Risk Rating**: 🟡 High

Why These Price Ranges Matter Low-float, low-price stocks often exhibit mechanical advantages, including the potential for rapid price movements. Due to limited shares available for trading, even modest buying pressure can lead to significant price spikes. Furthermore, these stocks tend to attract speculative interest, often leading to volatility that savvy traders can capitalize on.

How to Trade Them Safely When trading low-priced stocks, position sizing is critical. Traders should avoid allocating more than 1-2% of their total portfolio to any single position. Utilizing limit orders can help manage entry points effectively, minimizing slippage. Additionally, timing trades around catalysts—such as earnings announcements or product launches—can enhance potential returns while managing risk.

Catalyst Calendar - **SNDL**: Upcoming legalization discussions in several states (Q3 2026) - **MVIS**: Product launch expected in Q2 2026 - **CLOV**: Earnings report due on July 15, 2026 - **ZOM**: Product launch on July 20, 2026

Educational content only. Not financial advice. DYOR.